Letetresgene autoleucel Engineered T Cells in NY-ESO-1 Positive participants with Advanced Myxoid/ Round Cell Liposarcoma

Trial Identifier: 208469
Sponsor: GlaxoSmithKline
Collaborator:
NA
Start Date: December 2016
Primary Completion Date: November 2021
Study Completion Date: March 2022
Condition: Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
United States, Florida Tampa, Florida, United States, 33612
United States, Michigan Ann Arbor, Michigan, United States, 48109
United States, Missouri St. Louis, Missouri, United States, 63110
United States, New York New York, United States, 10065
United States, Ohio Columbus, Ohio, United States, 43210
United States, Texas Houston, Texas, United States, 77030